La terapia con aspirina nella prevenzione cardiovascolare primaria. Documento di consenso intersocietario Italiano

Translated title of the contribution: Therapy with aspirin in primary cardiovascular prevention. Italian inter-society consensus document

Massimo Volpe, Maurizio Giuseppe Abrignani, Claudio Borghi, Sergio Coccheri, Paolo Gresele, Giuseppe Patti, Bruno Trimarco, Raffaele De Caterina

Research output: Contribution to journalArticlepeer-review

Abstract

The indications for the use of aspirin in primary cardiovascular prevention continue to be a source of intense debate, with major international guidelines providing conflicting advices. This document, written by delegates of the main Italian scientific societies dealing with cardiovascular prevention and modeled on a similar document by the European Society of Cardiology Working Group on Thrombosis, reviews the evidence in favor and against the use of aspirin therapy in primary prevention based on data cumulated so far, including recent data linking aspirin with cancer protection. While awaiting the results of several ongoing studies, this document argues for a pragmatic approach to the use of low-dose aspirin in primary cardiovascular prevention, and suggests its use in patients at high cardiovascular risk, defined as ≥2 major cardiovascular events (death, myocardial infarction, or stroke) projected per 100 person-years, who are not at increased risk of bleeding.

Translated title of the contributionTherapy with aspirin in primary cardiovascular prevention. Italian inter-society consensus document
Original languageItalian
Pages (from-to)442-451
Number of pages10
JournalGiornale Italiano di Cardiologia
Volume15
Issue number7-8
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Therapy with aspirin in primary cardiovascular prevention. Italian inter-society consensus document'. Together they form a unique fingerprint.

Cite this